Background-Nuclear reprogramming inculcates pluripotent capacity by which de novo tissue differentiation is enabled.
C oerced expression of defined transcription factors triggers nuclear reprogramming of somatic cells, resulting in the reversal of cell fate and re-entry into an embryonic-like state. 1 Stem cells bioengineered in this way are commonly referred to as induced pluripotent stem (iPS) cells and retain the capability of differentiating into a wide array of cellular lineages and tissue types. 2 Recently, iPS cell technology has been applied to model disease pathobiology and to assess drug cardiotoxicity. [3] [4] [5] [6] [7] Beyond these emergent diagnostic applications, preclinical studies also demonstrate the promise of iPS cell derivatives in the treatment of heart disease. 8, 9 The translational value of iPS cell technology, however, hinges on ensuring reprogramming fidelity and canonical differentiation capacity. [10] [11] [12] [13] 
Editorial see p 571 Clinical Perspective on p 676
Ectopic transcription factor expression required to inculcate pluripotent programs introduces uncertainty in downstream developmental predictability. 14, 15 Integrative and nonintegrative reprogramming strategies [16] [17] [18] demonstrate variable residual transgene expression levels. Sustained presence of reprogramming transgenes after the initial induction of pluripotency affects the transcriptional profile of iPS cells and influences their epigenetic signature, 19 resulting in increased dissimilarities when compared with embryonic stem cells. 20 Residual transgene expression may affect differentiation of reprogrammed cells, 21 a limitation largely alleviated when the expression of reprogramming factors is transient in nature. 22 Yet, the consequences of the anachronistic and ectopic stemness load, imposed by nuclear reprogramming, on iPS cell cardiogenicity remain to be established. To address the influence of sustained transgene integration on cardiogenic cell fate decisions would require accounting for the clonal variability intrinsic to pluripotent cells, 23 while simultaneously enabling integration/removal of reprogramming transgenes.
Here, a transposon/transposase system was used, which enables inducible expression and nuclease excision of pluripotent transgenic sequences from reprogrammed cells. 24 iPS progeny devoid of transgenes demonstrated a cardiac differentiation competency superior to that of transgene-containing clones, indicating an advantage of integration-free approaches for production of genuine cardiogenic derivatives.
Methods iPS Cells With On/Off Reprogramming Transgene Load
iPS cell lines were generated from mouse embryonic fibroblasts derived from 15.5 days post coitum ROSA26-rtTA-IRES-GFP embryos (Gt(ROSA)26Sor tm1.1(rtTA,EGFP)Nagy strain) using the piggyBac transposon technology. Mouse embryonic fibroblasts were transfected with the inducible transgene-containing reprogramming cassette PB-TET-MKOS (which includes Myc, Klf4, Oct4, and Sox2) plus the transposase plasmid pCyL43 PB. 25 The medium was supplemented with 1.5 µg/ mL doxycycline 24 hours after transfection to induce transgene expression. Clones with embryonic stem cell morphology were picked and maintained on mytomycin-treated mouse embryonic fibroblasts. For transgene cassette removal, multiple lines containing the PB-TET-MKOS construct were transiently transfected with the pCyL43 PB transposase and treated with 1 µg/mL puromycin to select transfected cells. Transgene-free cells were seeded at low density and clones picked after 5 days in culture. 24 Excision of reprogramming transgenes enabled production of iPS cells from a common origin, yet with all or none transgene content ( Figure 1 ). Transgene overexpression in transgene-containing cells was achieved by a 24-hour doxycycline pulse before differentiation. According to an IRES-β-galactosidase component within the inducible construct, transgene upregulation was probed by β-galactosidase expression monitored through LacZ staining or by polymerase chain reaction (PCR) using transgene-specific primers.
iPS Cell Differentiation
Cells were maintained undifferentiated in mouse embryonic stem cell medium supplemented with 15% serum and leukemia inhibitory factor. Pretreatment consisted of exposure to 1.5-µg/mL doxycycline in embryonic stem cell maintenance medium for 24 hours (day −1 to day 0) to reactivate/overexpress reprogramming factors. Differentiation was achieved through embryoid body (EB) formation using hanging drops during 48 hours, followed by 48 hours of suspension culture in differentiation medium supplemented with 20% fetal bovine serum (without leukemia inhibitory factor) and plating on gelatinized plates. 26, 27 Cells were sampled from undifferentiated cultures (day 0) and after 5, 8, or 10 days of differentiation for PCR analysis. Beating activity was monitored daily and EBs containing beating areas quantified in triplicates after 7 days of differentiation. Cardiomyocytes were isolated at day 9. To this end, cultures were dissociated and separated using a Percoll density gradient, 28 and isolated cardiomyocytes plated for ≥12 hours before characterization.
Teratoma Formation
All animal studies were conducted in accordance with institutional guidelines. Undifferentiated iPS cells were injected subcutaneously into the flank of immunodeficient mice (500 000 cells/injection, 2 injection sites/mouse). Tumors were harvested 6 to 8 weeks after injection, flash frozen, and histologically processed. Cryosections (10 µm) were stained with hematoxylin-eosin before imaging. 14
Cell Staining
Alkaline phosphatase was revealed using AS-BI phosphate-based detection (Millipore, SCR004). For LacZ visualization, samples were fixed and X-gal-stained overnight. Immunostaining was performed using anti-α-actinin (Sigma A7811) 1:200, anticonnexin 43 (Millipore AB1728) 1:50, anti-myosin heavy chain (MHC, Abcam) 1:250, anti-myosin light chain 2a (MLC2a, Synaptic Systems 311011) 1:250, anti-cardiac troponin T (Thermo 1:200), and Alexa 488 conjugated anti-myosin heavy chain (MF20, eBiociences 1:100) primary antibodies. Secondary antibodies (Invitrogen), goat antimouse IgG Alexa Fluor 568 (A11031), and goat antirabbit IgG Alexa Fluor 488 (A11008) were used at 1:250 dilution. Nuclei were labeled with 4,6-diamidino-2-phenylindole (Invitrogen). Images were acquired by laser confocal microscopy (Zeiss LSM 510 Axiovert). Calcium dynamics were tracked on a Zeiss LSM live 5 confocal microscope after cells were loaded with Fluo-4 AM (Invitrogen) for 15 minutes at 37°C. 28
Fluorescence-Activated Cell Sorter Analysis
iPS cells differentiated for 9 and 11 days were dissociated for flow cytometry. Specifically, single-cell suspensions were fixed in 1% formaldehyde for 20 minutes, washed once in 1× PBS and stored at 4°C. Cells were initially treated with live/dead stain (Invitrogen L10119) for 30 minutes at 4°C, washed once with 1× PBS and subsequently permeabilized at room temperature in 0.1% Triton-X 100 for 3 minutes. After a wash with ice-cold 1× PBS, cells were stained with Alexa 488 conjugated MF20 29 (Affymetrix eBioscience 53-6503-82) for 30 minutes at 4°C. After a final wash in 1× PBS, a minimum of 25 000 total events per sample were collected on a Gallios flow cytometer (Beckman Coulter). Flow data were analyzed using the Kaluza software (Beckman Coulter).
Electron Microscopy
Cells were fixed in situ with 1% glutaraldehyde and 4% formaldehyde in 0.1 mol/L PBS (pH 7.2), processed for ultrastructural evaluation in phosphate-buffered 1% OsO 4 , stained en bloc with 2% uranyl acetate, dehydrated in ethanol and propylene oxide, and embedded in low-viscosity epoxy resin. Thin (90 nm) ultramicrotome sections (Reichert Ultracut E) were placed on mesh copper grids and stained with lead citrate. Micrographs were taken on a JEOL 1200 EXII electron microscope. 26
Polymerase Chain Reaction
Gene expression was probed by real-time-PCR. Total RNA was extracted using gDNA Eliminator and RNeasy columns (Qiagen, Valencia, CA). cDNA was prepared using Superscript III First Strand (Invitrogen). 28 Mouse Gapdh was used as normalizing control. Primers used included predesigned Sox2 ( Table I in the Data Supplement.
Patch Clamp Electrophysiology and Sympathomimetic Challenge
Isolated cardiomyocytes were plated on laminin-coated coverglasses. Membrane potential and ion currents were measured by patch-clamping in whole-cell configuration using current-or voltage-clamp mode (Axopatch 1C; Axon Instruments), respectively. 28 Action potential profiles and voltage-current relationships were acquired and analyzed with in-house software. Cells were superfused with Tyrode solution containing (in mmol/L) 137 NaCl, 5.4 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 HEPES, and 5.5 glucose (pH adjusted to 7.3 with NaOH). To discriminate ion currents, the bath solution was supplemented with nifedipine (10 µmol/L), a specific L-type calcium channel blocker, and verapamil (100 µmol/L), which blocks L-type calcium channels and sodium channels at this concentration. Alternatively, the bath solution was replaced by sodium-free Tyrode in which NaCl was substituted by choline-chloride to maintain molarity. Forskolin (10 µmol/L) was used as a sympathomimetic agent to stimulate L-type calcium channel activity by activating the andenylate cyclase-protein kinase A cascade. Patch pipettes (5-10 mol/LΩ) containing (in mmol/L) 140 KCl, 1 MgCl 2 , 10 HEPES, 5 EGTA, and 5 mmol/L ATP (pH adjusted to 7.3 with KOH) were used for electrophysiological measurements performed at 34±1°C set by a Peltier thermocouple temperature controller. Beating areas from day 9 to 20 differentiated cultures were manually dissected and replated onto coverglasses. Cells were treated with isoproterenol (2-10 µmol/L) 24 hours later, and beating activity was recorded. Images were processed with NIH Image J and a customized Matlab (Mathworks) program.
Statistics
Data are presented as mean±SEM. The Kolmogorov-Smirnov normality test was implemented before comparisons between samples (P>0.05 for all samples indicating normal distribution). Comparisons between means of normally distributed samples were performed using Student t test as recently validated for extremely small sample sizes. 30 All statistics analyses were performed using SigmaPlot 11 (Systat Software Inc, San Jose, CA). A P value <0.05 was predetermined as significant.
Results

Overexpressed Reprogramming Factors Compromise Cardiac Differentiation of iPS Cells
The effect of imposed pluripotency gene expression on the differentiation potential of iPS cells was gauged by transient induction of integrated reprogramming transgenes ( Figure 1 iPS cells containing the c-Myc, Klf4, Oct4, and Sox2 reprogramming factor cassette were differentiated (transgene-uninduced iPS cells; Figure 1A ) or pulsed for 24 hours with doxycycline immediately before differentiation to overexpress reprogramming transgenes transiently (transgene-induced iPS cells; Figure 1A ). At day 0, LacZ staining in transgene-induced iPS cells demonstrated robust activation of exogenous transgenes ( Figure 2B ), whereas staining was undetectable in control iPS cells (Figure 2A ). 24 Reactivation of exogenous transgenes was confirmed by semiquantitative PCR using primers ( Table I Collectively, this suggests that overexpression of ectopic pluripotency genes may abrogate rollout of differentiation pathways, maintaining iPS cells in a pluripotent configuration. Next, induced and uninduced transgene-containing iPS cells were differentiated according to 3-dimensional EB aggregates. Regardless of doxycycline pretreatment, by day 6 of differentiation, EBs were morphologically indistinguishable and lacked residual transgene expression indicated by the lack of detectable LacZ enzymatic activity ( Figure 2D and 2E) . Gene expression profiling at day 8 revealed homogeneous expression of the noncardiogenic genes Sox2, Oct4, Lhx1, and Gsc ( Figure 2F , left). Yet, cardiac-specific gene expression according to αMHC, βMHC, and cTnl was repressed in the doxycycline pretreated group (P=0.008, 0.003, 0.01, respectively; Figure 2F , middle), and associated with reduced beating activity from 30% in EBs without doxocycline induction to <5% after transient transgene induction (P=0.0006; Figure 2F 
Excision of Reprogramming Transgenes Enables Cardiogenic Competency
Transposase-based removal of integrated reprogramming factors did not alter features of pluripotency in derived transgenefree iPS cells ( Figure 1B) . Cell morphology, ultrastructure, and biomarker expression were equivalent for transgene-free when compared with those for transgene-uninduced iPS cells, the latter containing doxycycline inducible transgenes (Figure 3A) . Sustained pluripotency after reprogramming cassette removal in transgene-free iPS cells was comparable with transgene-containing counterparts as documented by equivalent teratoma formation containing derivatives from all 3 germinal layers ( Figure III in the Data Supplement).
To verify the absence of inducible transgenes, factor-free iPS cells were treated with doxycycline for 24 hours to quantify possible residual expression. Exogenous transcripts were undetectable in transgene-free cells with or without doxycycline induction, demonstrating absence of the reprogramming cassette ( Figure I in the Data Supplement). In addition, factor-free iPS cells did not display induction of LacZ after doxycycline treatment ( Figure 3B ). Transgene-free iPS cells maintained alkaline phosphatase staining similar to transgene-containing counterparts ( Figure 3B ). Moreover, the expression pattern of Oct4, Sox2, Fgf4, Lhx1, Gsc, and Flk1 genes, examined from pluripotent day 0 to partially differentiated day 8, was also equivalent ( Figure 3C ; Figure IV in the Data Supplement).
Differentiation of factor-containing and factor-free iPS cells gave rise to cardiac tissue as demonstrated by the presence of cardiac-related structural and functional attributes. Within developing EBs, transgene-free differentiating cells consistently beat by day 7, whereas similar levels of spontaneous contractility appeared 24 hours later in transgene-containing cells. As further differentiation progressed, factor-free progeny demonstrated a 20% increase in beating areas when compared with the lower cardiogenic potential inherent to factor-containing counterparts (P=0.033, 0.006, 0.008, and 0.027, respectively; Figure 4A ). Because increased passage of iPS cell lines is associated with alterations of pluripotent properties, 31, 32 and given that factor-free cells require additional passages to remove the transgene cassette, cardiogenic potential was re-evaluated at an advanced passage. Despite extended culture beyond the threshold of influence for residual memory from donor source, the cardiogenicity of factor-free cells remained higher relative to factor-containing counterparts ( Figure 4A ).
Functional proficiency of iPS derivatives that did not contain residual transgenes was supported by gene expression data. Notably, transgene-free cells displayed higher induction of cardiac actin, cTnl, αMHC, and βMHC genes when compared with transgene-containing iPS cells (P=0.07 for actin, 0.01 for cTnl, 0.04 for βMHC, and 0.02 for αMHC, respectively; Figure 4B ). Expression of endodermal (AFP and HNF4) and ectodermal (Nestin, Pax6, and Sox1) genes was not altered in the presence of the reprogramming cassette. During the course of differentiation, endoderm-and ectoderm-related genes displayed similar patterns of expression in transgene-containing and transgene-free cells ( Figure V in the Data Supplement).
By the end of the differentiation process, both transgenecontaining and transgene-free lines were capable of generating cardiomyocytes containing sarcomeric patterns visualized by immunostaining for contractile components, including α-actinin, myosin light chain 2a, and MHC ( Figure 4C ; Figure  VI in the Data Supplement for additional cell lines).
Independently, the cardiogenicity inherent to transgene-free cells was validated by quantitative flow cytometry. In agreement with the above results, beating activity determined for 1 transgene-containing line and 3 daughter transgene-free lines showed higher beating activity in the absence of transgene integration ( Figure 4D) , correlating with increased staining for myosin heavy chain (MF20; Figures 4E-4G ). Of note, the extent of the observed differences seemed to vary between clones and to decrease as differentiation progressed ( Figure 4F and 4G) .
Disruption of cardiogenicity in the presence of the reprogramming cassette was associated with detectable levels of exogenous transgene expression in uninduced transgene-containing cells even after extended differentiation, suggesting leaky expression even in the absence of doxycycline treatment (Figures I and VII in the Data Supplement). Permanent excision of integrated reprogramming transgenes was thus required to liberate differentiating cells from residual pluripotency expression and enabled timely execution of cardiogenic programs. 
Transgene-Free iPS Cells Generate Maturing Cardiomyocytes
Factor-free iPS cells achieved features associated with maturing cardiomyocytes (Figure 4A-4C) . Consistent with the cardiogenic gene expression profile for sarcomeric structures, factor-free iPSderived progeny isolated according to density gradient separation contained structured arrays of cardiac contractile proteins, α-actinin, and myosin light chain 2a, visualized by immunostaining ( Figure 5A and 5B) . Defined organized bands together with myocyte-specific staining indicated a maturing phenotype after 9 days of differentiation (Figure 4) . Electron microscopy revealed a structured array of sarcomeric elements, including high-density Z discs ( Figure 5C ) and distinctive alternating patterns of actin and myosin fibers in transverse sections (Figure 5C, inset) . Structures responsible for electric conduction were present with the gap junction protein connexin 43 detected between adjacent cardiomyocytes ( Figure 5D ). Ultrastructural analysis demonstrated desmosomal formations and gap junctions consistent with organized cell-cell communication ( Figure 5E and 5F ). Cardiomyocytes derived from transgene-free iPS cells and loaded with the calcium probe Fluo-4 AM exhibited rhythmicity corresponding to calcium handling in diastole and systole ( Figure 5G ). A subset of transgene-free iPS-derived cells contracted regularly and demonstrated spontaneous sodium channel-triggered action potential activity ( Figure 5H ). Removal of external calcium shortened the action potential plateau, consistent with calcium-dependent regulation of depolarization ( Figure 5H ). Factor-free iPS-derived progeny that did not display automaticity responded to electric stimulation and displayed action potentials modulated by the L-type calcium channel blocker nifedipine ( Figure 5I ). Overall, these data suggest that pluripotent cells that do not contain integrated residual transgenes after the reprogramming process are capable of differentiating into functional cardiac cytotypes.
Reprogramming Factor Removal Facilitates Adrenergic Responsiveness
Examination of membrane currents in response to ramp pulses, from −110 to +80 mV under voltage-clamp mode, revealed inward and outward current components in both factor-containing and factor-free populations ( Figure 6A and 6C, arrow and arrowhead) . Inward Ca 2+ and Na + currents were discriminated on single-pulse stimulation by nifedipine (10 µmol/L) and the calcium channel blocker verapamil, which inhibits Na + channels at the concentration (100 µmol/L) used herein. 33 Combined application of nifedipine and verapamil blunted membrane depolarization ( Figure 6B and 6D). The contribution of sodium currents to membrane excitability in factor-free iPS-derived cells was validated by removal of external sodium ions ( Figure 6D ). Similar to factor-containing cells, factor-free iPS-derived cardiomyocytes were responsive to sympathetic regulation. Indeed, in the voltage-clamp mode with ramp or single-pulse stimulation, forskolin (10 µmol/L), an activator of adenylate cyclase that raises intracellular cAMP levels and promotes calcium channel opening through phosphorylation by protein kinase A, induced enhanced calcium currents (Figure 7) . At EB level, the performance of cardiac progeny was challenged by a sympathomimetic stimulus. On treatment with isoproterenol, a positive chronotropic effect was consistently observed in transgene-free cells showing increased rates of beating activity as represented by the decrease in time elapsed between beats (Figure 8 ). Although structural components of electromechanical coupling were visualized even in the sustained presence of the reprogramming cassette, a physiological chronotropic response to sympathetic stimulation was consistently observed only in cardiomyocytes derived from transgene-free iPS cells ( Figure 8C and 8D ). This suggests that the cascade necessary for adequate receptor-to-contraction communication is operational after transposase-assisted elimination of reprogramming transgenes. Nuclear reprogramming using the piggyBac transposon/transposase system thus enables generation of transgene-free iPS cells with a proficient cardiogenic potential yielding maturing cardiomyocytes that display a canonical adrenergic response absent from transgene-containing counterparts.
Discussion
Reprogramming somatic sources offers an unprecedented strategy to supply autologous pluripotent stem cells and their derivatives, enabling a spectrum of individualized regenerative applications. 34, 35 However, rollout of stemness programs outside the normal developmental timetable carries the risk of perturbing transcriptional regulators of cell fate, 36 challenging the use of nuclear reprogramming technology. [37] [38] [39] In fact, the developmental potential of iPS cells is susceptible to extended transgene exposure, 19, 22, 40 with incomplete silencing of reprogramming-related genes increasing the cardiogenic variability of reprogrammed cells. 41 Here, we provide evidence that removal of integrated reprogramming factors favors cardiogenesis from iPS cells.
Specifically, the high precision and footprint-free piggyBac nuclease technology 42, 43 was used as a tool for head-to-head comparison of cells containing integrated reprogramming factors (induced or uninduced) versus cells after traceless removal of transgenic sequences within the same genetic background. Transient induction of ectopic reprogramming factors before differentiation did not alter the pluripotent status of iPS cells, but nullified cardiogenic competency concomitant with dysregulated gene expression on lineage respecification. Expression of gastrulation markers, precardiac genes, and beating activity were all repressed after pulsed transgene induction. These findings are in line with previous reports demonstrating that the fine-tuned equilibrium between pluripotency and differentiation is susceptible to pluripotency factor misregulation. 14 In this regard, cardiogenic gene expression and subsequent cellular transformation are dependent on the dynamic and transient interactions between transcription factors and target sequences. 44 Case in point, the Oct4 transcription factor switches from serving as the binding partner of pluripotency-related Sox2 in stem cells to partnering with the endoderm-related Sox17 within few days of differentiation, releasing pluripotent gene expression patterns toward cardiogenic pathways. 45 In the present study, initiation of ectopic reprogramming pathways resulting from the exogenous expression of c-MYC, KLF4, OCT4, and SOX2 subsequently interrupted sequential cardiogenic pathways, thus highlighting the susceptibility of the pluripotency/differentiation balance. 43, 44, 46, 47 Reducing desynchronized pluripotency programs through a nonintegrative reprogramming platform that minimizes residual transgene expression will help to ensure a predictable and reproducible cardiogenic outcome.
Spontaneous beating activity and cardiac-specific gene expression appeared earlier in iPS cells devoid of integrated transgenes. After spontaneous differentiation, attributes indicative of functional cardiomyocytes, such as maturing sarcomeric structures, were present both in transgene-containing and transgene-free iPS cells. Electromechanical coupling with appropriate response to Na + and Ca 2+ channel blockade and intracellular cAMP activation were observed across iPS cell lines. Yet only transgene-free derivatives demonstrated a positive chronotropic response to isoproterenol stimulation. Translation of sympathetic activation into increased beating rates involves a complex and specialized cascade of events from receptor stimulation through adenylyl cyclase activation to phosphorylation of ion channels and contractile proteins. 48 The canonical responsiveness to β-adrenergic stimulation or forskolin-dependent activation of cAMP production in factor-free derivatives with an active adrenergic signaling system established transgene-free-derived cardiomyocytes as genuine reagents for toxicological and pharmacological applications.
The present experimental design did not control for potential effects caused by integration of the piggyBac cassette itself, independent of its transgene content. It should, however, be noted that detection of pluripotency transgene expression outside the natural timeframe (Figures I and VII in the Data Supplement) along with the inverse relationship observed between ectopic pluripotency factor levels and cardiogenicity suggests that the transposon content is the active element regulating the observed outcome.
Although the present study leverages a piggyBac platform, extra steps are required to produce integration-free iPS cells using this technology. In this regard, several nonintegrative approaches enabling nuclear reprogramming have been developed, including introduction of episomal vectors, single-strand RNA virus, synthetic mRNA or proteins, 18, [49] [50] [51] as well as an efficient platform for generation of iPS cells based solely on chemical compounds. 52 Some of these technologies have shown proficient production of cardiac derivatives, 53 underscoring the feasibility of transgene-free cardiomyocyte generation.
In summary, the transposon/transposase strategy applied here enabled discrimination, within the same genetic background, of the cardiogenic potential of iPS cells containing or devoid of the inserted transgenes initially required for nuclear reprogramming. Our results reveal higher cardiogenic proficiency of transgene-free iPS cells, highlighting the importance of implementing reprogramming strategies that result in transgene-free iPS cells for cardiovascular applications.
